Connect with us on Facebook Follow us on Twitter Join our LinkedIn Group Subscribe to us on YouTube Share with us on Google+ Subscribe to our RSS feed

January 12, 2018

U.S. News

Mary Kay to Sponsor Exclusive Dermatology Symposium

Mary Kay Inc., will sponsor an exclusive symposium at the prestigious International Investigative Dermatology (IID) Meeting in 2018 to be held in Orlando in May.

IID brings together the world’s finest researchers in the fields of cutaneous biology and related disciplines. It is organized jointly every five years by the world’s pre-eminent skin health research organizations from Europe (European Society for Dermatological Research), Asia (The Japanese Society for Investigative Dermatology) and North America (Society for Investigative Dermatology).

“Helping advance the knowledge of the effects of pollution on skin health, and discovering new perspectives and intervention strategies demonstrates Mary Kay’s commitment to skin science,” says Dr. Lucy Gildea, Mary Kay’s Chief Scientific Officer. “Our sponsorship of IID is a remarkable opportunity for Mary Kay to exchange ideas and findings with our colleagues in industry and academia regarding pollution and skin health.”

The IID sponsorship is just the latest in a series of Mary Kay partnerships with the scientific and academic communities. Mary Kay has long supported research grants and projects with the University of Texas Southwestern Medical Center in both skin care and women’s health. Mary Kay has also been involved with the American Academy of Dermatology and the Society of Cosmetic Chemists.

Responding to the rising concern of pollution and declining air quality around the world, Mary Kay’s most recent research initiative focuses on the harmful effects of air pollution, UV radiation and other environmental stressors on the skin.

Mary Kay invests millions of dollars annually in skin health research and development, confirming Mary Kay’s status as one of the world’s leading cosmetic industry innovators. The recent appointment of Dr. Gildea, Ph.D., Cell and Molecular Biology, as Chief Scientific Officer as well as the groundbreaking of a $125 million-dollar state-of-the-art manufacturing and R&D facility in Lewisville, Texas, further extend Mary Kay’s leadership in science-based product development and innovation.

Each year, Mary Kay conducts hundreds of thousands of scientific tests on its latest skin care innovations to ensure the highest standards of safety, quality and performance. Mary Kay Inc. has set a company milestone with more than 1,400 patents for products, technologies and packaging designs in its global portfolio.